Table 3.
Univariate and multivariate analysis of postoperative overall complications
| Variables | No complications | Complications | Univariate analysis | Multivariate analysis | |
|---|---|---|---|---|---|
| 135 | 145 | P | OR (95% CI) | P | |
| Gender (male/female) | 116/19 | 122/23 | 0.675 | ||
| Age (year) (≤ 50 vs > 50) | 69/66 | 62/83 | 0.027 | ||
| Diabetes (yes vs no) | 9/126 | 13/132 | 0.475 | ||
| Hypertension (yes vs no) | 24/111 | 29/116 | 0.635 | ||
| ASA grading (≤ 2 vs > 2) | 101/34 | 94/51 | 0.069 | ||
| Total bilirubin (μmol/L) | 15.2 ± 8.0 | 33.0 ± 61.9 | 0.001 | ||
| Albumin (g/L) | 40.7 ± 5.1 | 37.7 ± 5.5 | < 0.001 | 0.922 (0.871–0.975) | 0.004 |
| ALT (U/L) | 38.0 ± 23.0 | 69.4 ± 73.3 | <0.001 | 1.012 (1.001–1.022) | 0.026 |
| AST (U/L) | 37.7 ± 19.7 | 74.4 ± 81.9 | < 0.001 | ||
| GP73 (≤ 80.9 vs > 80.9 ng/mL) | 108/27 | 53/92 | < 0.001 | 3.996 (2.152–7.421) | < 0.001 |
| Size of tumor (cm) | 6.1 ± 3.4 | 6.3 ± 3.8 | 0.749 | ||
| Number of tumors | 1.1 ± 0.4 | 1.2 ± 0.5 | 0.521 | ||
| Operation time (min) | 200.9 ± 65.4 | 263.9 ± 267.9 | 0.008 | ||
| Blood loss (mL) | 546.1 ± 510.5 | 1051.0 ± 1197.5 | < 0.001 | ||
| Intraoperative RBC transfusion | 1.9 ± 2.0 | 3.8 ± 4.3 | < 0.001 | 1.206 (1.069–1.359) | 0.002 |
AST aspartate aminotransferase, ALT alanine aminotransferase, ASA American Society of Anesthesiology, RBC red blood cell